Robert A. Craig II, PhD

Robert A. Craig II, PhD, is a scientist, leader, and entrepreneur with more than 15 years of combined academic and industry experience. At Tenvie Therapeutics, Dr. Craig leads the Small Molecule Discovery team that is responsible for discovering and optimizing lead chemical matter across the Tenvie pipeline, which includes a focus on neurological diseases and the identification of highly CNS-penetrant small molecules that are suitable for clinical development. Prior to Tenvie, Dr. Craig served as an Entrepreneur-in-Residence at Stanford University, where he was responsible for identifying and advancing therapeutic programs at the interface of academia and industry, and worked in the Small Molecule Discovery group at Denali Therapeutics. Dr. Craig has co-authored >15 peer-reviewed publications and is an inventor on >20 patents. He received a B.S. from Davidson College, earned his PhD in Organic Chemistry at the California Institute of Technology, and completed postdoctoral training in Organic Chemistry & Neuroscience at Stanford University.